Associations Between Major Depression, Health-risk Behaviors, and Medication Adherence Among Hiv-positive Adults Receiving Medical Care in Georgia by Culbreth, Rachel et al.
   Original Research  
Associations between major depression, health-risk behaviors, and 
medication adherence among HIV-positive adults receiving medical 
care in Georgia  
 
Rachel Culbreth, MPH1, Shanta R. Dube, PhD, MPH1, and David Maggio, MPH2 
  
1School of Public Health, Georgia State University, Atlanta, GA, and 2Georgia Department of Public Health, 
HIV/AIDS section, Atlanta, GA 
 
Corresponding Author: Rachel Culbreth  P.O. Box 3995, Atlanta, GA 30302-3995  404-293-1977  RCulbreth@student.gsu.edu 
 
ABSTRACT 
Background: There are approximately 1.2 million people in the United States living with HIV, and 25.6% 
of HIV-positive adults suffer from depression. The purpose of this study is to examine the contribution of 
depression to substance use and medication adherence among HIV-positive adults receiving medical care 
for HIV in Georgia.  
 
Methods: Secondary data with a probability sample of 775 HIV-positive adults who took part in the 2009-
2013 Georgia Medical Monitoring Project (MMP) were analyzed. Descriptive analyses and multivariate 
logistic regressions were conducted to assess relationships between depression and current cigarette 
smoking, injection drug use, other non-injection drug use, and medication adherence, adjusting for 
sociodemographic covariates (age, gender, race, and education). All analyses accounted for non-response 
and complex sampling design. 
 
Results: Among HIV-positive adults in Georgia, 8.5% met the criteria for major depression, including 
13.7% of women and 6.5% of men. Heterosexual adults had a higher percentage of major depression 
(10.7%) compared to adults who identified as bisexual (7.4%) or homosexual (5.8%). Major depression 
was also higher among adults with a high school diploma or GED (12.7%) compared to adults with a 
higher level of education (5.2%). Major depression was associated with a greater odds of current cigarette 
smoking (AOR 2.7; 95% CI: 1.5, 5.2) and other non-injection drug use (2.5; 95% CI: 1.4, 4.4), after 
adjusting for sociodemographic variables. The three measures of medication adherence were not 
statistically significantly associated with major depression.  
 
Conclusions: As previously observed for the general population, we found, among HIV-positive adults, 
significant associations between depression and smoking and other non-injection drug use. Because HIV-
positive adults have ongoing encounters with healthcare providers, screening and treatment for depression 
and other co-morbid substance use is needed to reduce an additional health burden in this population. 
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Within the United States, approximately 1.2 
million people are currently living with human 
immunodeficiency virus (HIV) infections 
(CDC - HIV/AIDS). The southern states, 
including Georgia, have the highest burdens of 
HIV (CDC - HIV/AIDS; Southern AIDS 
Coalition). According to the Georgia Department 
of Public Health HIV/AIDS Epidemiology 
Section, 50,436 people were living with HIV in 
Georgia as of December 31, 2012 (The Georgia 
Department of Public Health Fact Sheet: HIV 
Surveillance, Georgia, 2012). In 2011, Georgia 
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had the sixth highest HIV prevalence among 
adults and adolescents in the United States and 
ranked fourth highest for new HIV infections 
(The Georgia Department of Public Health Fact 
Sheet: HIV Surveillance, Georgia, 2012).  
 
Due to the advent of antiretroviral therapy 
(ART), persons with HIV are living longer. An 
estimated 36% of HIV-positive persons are 
prescribed ART medication, and 77% are virally 
suppressed and adequately adherent to ART 
medications (CDC - HIV/AIDS). Compared to 
the general population, persons with HIV still 
experience mental health disparities, including 
depression (Do et al., 2014). Depression is a 
serious mental and emotional disorder in which 
an individual experiences a loss of interest or 
pleasure in daily activities, often accompanied by 
other symptoms, such as changes in sleep 
patterns, fatigue, and irritability (American 
Psychiatric Association, 2000). Moreover, in 
major depressive disorder, individuals 
experience depressive symptoms for more than 7 
days of the previous 2 weeks (American 
Psychiatric Association, 2000). Compared to the 
general population, HIV-positive persons are 
between two to seven times more likely to be 
diagnosed with major depression (Do et al., 
2014; Hinkin, Castellon, Atkinson, & Goodkin, 
2001). An estimated 25.6% of HIV-positive 
adults suffer from depression, and 12.4% suffer 
from major depression (Do et al., 2014). 
Depression among HIV-positive persons, and in 
the general population, has been linked to 
adverse health outcomes and behaviors, such as 
cigarette smoking, substance use, and ART 
medication non-adherence (Arseniou, Arvaniti, 
& Samakouri, 2014; Mdodo et al., 2015). In 
more than 95 studies, there was an association of 
depression with non-adherence to ART 
medication (Gonzalez, Batchelder, Psaros, & 
Safren, 2011). However, one investigation found 
that participants who reported a high number of 
depressive symptoms were also likely to report a 
high rate of medication adherence compared to 
individuals reporting a smaller number of 
depression symptoms (Berger-Greenstein et al., 
2007).  
 
In addition to the association of depression with 
ART medication non-adherence, depression has 
been linked to substance use, including cigarette 
smoking, among both the general population 
(McClave, McKnight-Eily, Davis, & Dube, 
2010; Strine et al., 2012; Trosclair & Dube, 
2010) and those with HIV (Burnam et al., 2001; 
Dausey & Desai, 2003). HIV-positive adults are 
twice as likely to smoke compared to the general 
population, and less likely to quit smoking (quit 
ratio, 32.4% vs. 51.7%) (Mdodo et al., 2015). It 
is plausible that nicotine from cigarettes may 
help mitigate the depressive symptoms 
(Burkhalter, Springer, Chhabra, Ostroff, & 
Rapkin, 2005). A high prevalence of substance 
use coupled with mental illnesses is also evident 
among HIV-positive persons (Burnam et al., 
2001; Dausey & Desai, 2003). Between 10% and 
28% of persons living with HIV have co-
occurring mental illness and substance use 
disorders (Burnam et al., 2001; Dausey & Desai, 
2003). Depression and substance use disorders 
are also related to low medication adherence, 
creating a complicated mechanism of disease 
progression (Magidson et al., 2014). 
 
Currently, little is known about the associations 
between smoking, medication adherence, and 
substance use with depression among HIV-
positive adults receiving care in Georgia. For 
persons living with HIV, these adverse health 
outcomes and behaviors can negatively affect the 
longevity and quality of life (Helleberg et al., 
2015; Gonzalez et al., 2011; Mdodo et al., 2015), 
and the linkage between depression and these 
behaviors could inform treatment interventions. 
The purpose of this study was to examine, by use 
of data collected for the Georgia Medical 
Monitoring Project in the years 2009-2013, the 
association between major depression and 
current cigarette use, injection drug use, non-
injection drug use, and ART medication 
adherence, among adult Georgians receiving 




Institutional Review Board at Georgia State 
University determined the study to be exempt 
and approved the research. 
 
Participants/Setting 
The Georgia Medical Monitoring Project (MMP) 
is a surveillance system that collects data on 
behavioral and clinical aspects of persons living 
with HIV who are currently receiving medical 
care (“Georgia Medical Monitoring Project”). 
For purposes of the present study, a secondary 
analysis was conducted using aggregate MMP 
data for 2009, 2010, 2011, 2012, and 2013.  
 
MMP consists of a three-stage, probability 
sampling method, and Georgia is one of 26 states 
and cities across the United States to participate 
(“Georgia Medical Monitoring Project”). MMP 
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project areas are estimated to include more than 
80% of the total HIV/AIDS patients in the 
United States. To ascertain behavioral 
information, interviews are conducted either 
face-to-face or via phone, and medical record 
abstractions are used to obtain clinical 
information. To be eligible to participate, 
individuals were required to be HIV-positive, 18 
years of age or older at the time of the interview, 
and actively receiving medical care for HIV. 
Data from the Georgia MMP are weighted to 
produce a representative sample of all adult 
Georgians receiving medical care for HIV (Blair 
et al., 2011; Frankel et al., 2012; McNaghten et 
al., 2007). Once facilities are selected and agree 
to participate, patient lists are generated, and a 
sample of 400 Georgia patients are randomly 
selected.   
 
Independent Variables 
In MMP, depression is measured using the 
Eight-Item Patient Health Questionnaire (PHQ-
8) (Kroenke et al., 2009; Kroenke, Spitzer, & 
Williams, 2001). The PHQ-8 was adopted from 
the PHQ-9, which assesses the nine criteria 
associated with depression as defined by the 
Diagnostic and Statistical Manual of Mental 
Disorders, fourth edition (DSM-IV) (American 
Psychiatric Association, 2000). The ninth item, 
omitted from the PHQ-8, assesses suicidal 
ideations. Due to the fact that most of the 
interviewers are not trained mental health 
providers, this item was removed to create a 
more widely used tool, the PHQ-8 (Kroenke et 
al., 2009; Kroenke et al., 2001). The PHQ-8 is 
closely comparable to the PHQ-9 (Kroenke, 
Spitzer, Williams, & Löwe, 2010). According to 
a systematic review of the PHQ-9, the measure 
has demonstrated internal reliability or 0.86 to 
0.89 and external reliability of 0.84 in 
identifying depression in clinical settings and 
general population settings (Kroenke et al., 
2010).  
Methods used to identify individuals with major 
depression are consistent with the DSM-IV 
criteria (American Psychiatric Association, 
2000) and with methods used in a national MMP 
study (Do et al., 2014). The PHQ-8 asks if the 
individuals experienced certain symptoms within 
the last two weeks. They were considered to 
have major depression if they had five of the 
eight symptoms “more than half the days” of the 
last two weeks, and answered “more than half 
the days” in response to at least one of the first 
two questions: 1) “Little pleasure in doing 
things,” and 2) “Feeling down, depressed, or 
hopeless” (Do et al., 2014; Kroenke et al., 2009).  
 
Dependent Variables 
Injection drug use  
Participants who reported that they had used 
injection drugs in the past 12 months were 
classified as engaging in injection drug use. The 
interviewer explained that injection drugs for 
non-medical purposes include using drugs with a 
needle, “either by mainlining, skin popping, or 
muscling” (heroin, cocaine, heroin and cocaine 
together, crack, methamphetamine, 
amphetamines, oxycontin, steroids or hormones, 
or any other drug). 
 
Non-injection drug use  
Participants who reported that they had used 
non-injection drugs in the past 12 months were 
classified as engaging in non-injection drug use 
(methamphetamines, amphetamines or 
stimulants; crack; cocaine; downers such as 
Valium, Ativan, Xanax; painkillers such as 
OxyContin, Vicodin, or Percocet; hallucinogens 
such as LSD or mushrooms; and other drugs 
such as ecstasy, heroin or opium, marijuana, 
amyl nitrate, GHB, or ketamine).  
 
Current Cigarette Smoking 
Individuals were defined as current smokers if 
they answered “Yes” to “Have you smoked at 
least 100 cigarettes in your entire life?” and if 
they answered “Daily,” “Weekly,” or “Monthly” 
in response to “How often do you smoke 
cigarettes now?” (CDC DHDS). Non-smokers 
included both former smokers (smoked at least 
100 cigarettes but does not smoke now) and 
never smokers (did not smoke at least 100 
cigarettes).  
 
ART Medication Adherence 
ART medication adherence was assessed using 
MMP-calculated variables for three measures: 
dose non-adherence, special instructions non-
adherence, and schedule non-adherence. If 
participants reported less than 100% adherence 
to doses in the past 3 days, special instructions 
adherence, or adherence to medication schedule, 
they were classified as non-adherent in the 
corresponding category (Beer et al., 2012). 
 
Statistical Analyses 
All statistical analyses were conducted in 
February 2014 using SAS 9.2 (SAS Institute, 
Inc., Cary, NC). All analyses accounted for the 
complex survey design and included weights, 
and cluster and stratum variables. Multivariate 
logistic regression analyses were conducted to 
assess associations between major depression 
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and the four dependent variables while 
controlling for confounding factors that were 
identified through bivariate analyses and 
confounders previously documented in the 
literature. Chi-Square tests and Fisher Exact tests 
were performed to assess differences in 
demographics and outcome categories by 




The overall prevalence of HIV-positive adults 
with major depression was 8.5% (95% CI: 6.4%, 
10.5%) (Table 1). Among females, 13.7% (95% 
CI: 8.2%, 19.2%) were classified as having 
major depression, and 6.5% (95% CI: 4.6%, 
8.5%) of males met the criteria. Classified as 
having major depression were 10.7% (95% CI: 
7.1%, 14.2%) of heterosexual adults; 7.4% (95% 
CI: 2.2%, 12.5%) of bisexual adults; and 5.8% 
(95% CI: 3.2%, 8.3%) of homosexual, gay, or 
lesbian adults. In this category were 12.7% (95% 
CI: 8.7%, 16.8%) of persons with a high school 
education or GED and 5.2% (95% CI: 3.1%, 
7.4%) of those with a college education or 
higher. 
 
Table 1. Demographic characteristics and prevalence of dependent variables among HIV-positive 
Georgia MMP participants with major depression and without major depression, 2009-2013 










χ2 (df), p 
Gender, n (%)      











   Transgender 0 --- 9 ---  
Race/Ethnicity, n (%)      
    Alaskan Native/American      
    Indian 
1 --- 3 --- 7.3 (2), 
p=0.03* 
    Asian 0 --- 2 ---  










   Multi-Racial 7 --- 39 4.94% 
(2.58%-5.62%) 
 
Sexual Orientation, n (%)      

















    Other 2 --- 7 ---  
Age, n (%)      




    25-34 13 --- 108 13.81% 
(11.35%-16.26%) 
 
    35-44 9 --- 208 27.49% 
(23.95%-31.02%) 
 





    > 55 6 --- 142 17.17% 
(14.77%-19.57%) 
 
Education, n (%)      
    High School/GED or less 40 12.73% 338 43.11% 11.0 (1), 
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χ2 (df), p 
(8.65%-16.82%) (37.21%-49.02%) p=0.01* 





Current Smoker, n (%)      













Non-Injection Drug Use, n 
(%) 
     











Injection Drug Use, n (%)      
    Yes 2 --- 9 --- 4.54 (1), 
p=0.033* 







Non-Adherence, n (%) 
     











Medication Schedule  
Non-Adherence, n (%) 
     











Medication Dose  
Non-Adherence, n (%) 
     













Note. Weighted percentages were suppressed if estimates had a coefficient of variance >30%. A Gender chi-square test 
was performed comparing female to male, due to cell size of 0 in transgender depression category. A Race/Ethnicity 
chi-square test was performed assessing white, black, and other. Other included Asian, American Indian/Alaskan 
Native, and multiracial due to cell size of 0 in the Asian depression category. A Fisher exact test was performed for 
sexual orientation instead of Chi-Square test due to cell size <5 in other category.  
*Significant p-values <0.05 based on chi-square statistic.   
 
Among adults who met the criteria for major 
depression, 33.4% (95% CI: 17.0%, 49.7%) 
reported non-adherence to special instructions 
for ART medications, compared to 25.2% 
(95% CI: 21.3%, 29.2%) without major 
depression (Table 2). Additionally, 33.2% 
(95% CI: 17.8%, 33.6%) of adults with major 
depression reported non-adherence to 
medication schedule, compared to adults 
without major depression, 23.4% (95% CI: 
20.3%, 26.4%). However, the chi-square 
statistics for these differences were not 
J Ga Public Health Assoc (2016), Supplement to Vol. 6, No. 2 ISSN 2471-9773
http://www.gapha.org/jgpha/        188 Georgia Public Health Association
statistically significant. None of the logistic 
regression results for major depression and 
ART medication non-adherence were 
statistically significant, even after adjusting for 
age and any drug use. 
 
Table 2. Bivariate and multivariate logistic regression results for the associations between 
selected health behaviors and major depression among Georgia MMP participants, 2009-2013 
















         Major depression 
















Non-injection Drug Use 
         Major depression 
















Injection Drug Use 
         Major depression 



















         Major depression 


























Medication Schedule  
Non-Adherence 
         Major depression 





















Medication Dose  
Non-Adherence 
         Major depression 





















Note. Adjusted based upon bivariate analyses and the presence of confounders in the literature among noted 
variables. Current cigarette smoking, non-injection drug use, and injection drug use were adjusted for age, gender, 
race, and education. All of the medication adherence analyses were adjusted for age and any drug use.  
*Significant relationships at p<0.05 bolded. 
 
Current cigarette smoking prevalence among 
adults with major depression was nearly double 
that of adults without major depression, 61.8% 
(95% CI: 47.4%, 76.1%) versus 32.0% (95% CI: 
27.9%, 36.0%), respectively. After adjusting for 
age, gender, race, and education, the association 
between current cigarette smoking and 
depression was statistically significant (AOR: 
2.7, 95% CI: 1.5, 5.2).  
 
Of adults with major depression, 37.2% (95% 
CI: 24.4%, 50.1%) reported non-injection drug 
use in the past 12 months, whereas 21.0% (95% 
CI: 17.5%, 24.5%) of those without major 
depression reported such use. The non-injection 
drug most used was marijuana. After adjusting 
for age, gender, race, and education, the 
association between non-injection drug use and 
major depression was statistically significant 
(AOR 2.5; 95% CI: 1.4, 4.4).  
 
The prevalence of injection drug use by major 
depression status was suppressed due to a high 
coefficient of variation. The Fisher exact test for 
differences between injection drug use among 
adults with major depression and adults without 
major depression was not statistically significant 
(p=0.16). The unadjusted odds ratio was 
statistically significant for the association 
between injection drug use and major depression 
(AOR 3.9; 95% CI: 1.04, 14.4), however, after 
adjusting for potential confounders, the 
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association was no longer significant (AOR 2.7; 




To our knowledge, the present study is one of the 
first to examine the relationship between major 
depression and selected health behaviors among 
adults living with HIV in Georgia who are 
currently receiving medical care. Major 
depression was more prevalent among persons 
with HIV compared to the prevalence among the 
general population of U.S. adults (4.1%) (Do et 
al., 2014). This finding is not unexpected, since 
HIV-positive adults face adversities that may 
increase the risk of developing depression and 
depressive symptoms (Arseniou et al., 2014; 
Valente, 2003). HIV-positive individuals tend to 
have feelings of helplessness, a loss of hope, and 
despair associated with their HIV diagnosis, 
which can lead to the onset of depressive 
disorders (Leserman, 2008; Valente, 2003). A 
loss of social support, medication side effects, 
and distress associated with HIV status have also 
been linked to depression (Valente, 2003). In 
addition to psychosocial factors, biological 
processes may be involved in the relationship 
between depression onset and HIV infection 
(Leserman, 2008). Although the biological 
mechanisms are not known, a theory is that HIV 
infection of the central nervous system may lead 
to depression through damaged neurons and 
impaired synapse function (Valente, 2003).  
 
An aspect of the association between depression 
and HIV infection is that the chronicity of 
depression may affect the progression of HIV 
disease (Leserman et al., 2002; Leserman, 2003; 
Leserman, 2008). For example, one study found 
that, after controlling for ART medication 
adherence, HIV-positive women with clinical 
depression were twice as likely to die from AIDS 
compared to HIV-positive women without 
clinical depression; clinically depressed women 
also had significantly lower CD4+ cell counts 
compared to women without depression 
(Ickovics et al., 2001). These results indicate 
that, regardless of ART treatment, the effect of 
depression on HIV disease progression warrants 
attention by care providers who screen, diagnose, 
and treat depression in their HIV-positive 
patients.   
 
As found in the general population (Davis, 
Uezato, Newell, & Frazier, 2008), our findings 
indicate that HIV-positive adults with major 
depression engaged in non-injection drug use 
more frequently than HIV-positive adults 
without major depression. The use of such 
substances may exacerbate depressive disorders 
and increase engagement in other health risk 
behaviors, such as unprotected sex, which may 
lead to HIV transmission (Molitor, Truax, Ruiz, 
& Sun, 1998). Thus, the treatment of depression 
and co-morbid substance use disorders for HIV-
positive persons has implications for the 
prevention of HIV transmission.  
 
In our sample, the association between cigarette 
smoking and depression among HIV-positive 
adults is consistent with findings for the general 
population, in which 36.1% of adults with 
mental illness smoke cigarettes (McClave, 
McKnight-Eily, Davis, & Dube, 2010; Strine et 
al., 2012; Trosclair & Dube, 2010). Nicotine has 
psychoactive properties and may be used as self-
medication to ease symptoms of depression 
(McClave et al., 2010; Strine et al., 2012; 
Trosclair & Dube, 2010). Compared to the 
general population, HIV-positive persons who 
smoke are at an increased risk for cardiovascular 
disease, pneumonia, lung cancer, and liver 
cancer (Helleberg et al., 2013). There is also a 
substantial increase in mortality among smokers 
living with HIV (2013). These findings warrant 
interventions targeted at mitigating cigarette 
smoking among HIV-positive persons. 
 
Although, in more than 95 studies, the 
association between depression and medication 
non-adherence has been demonstrated (Gonzalez 
et al., 2011), in our study, the three measures of 
medication non-adherence were not associated 
with major depression. One possible reason for 
the lack of relationship found between 
depression and medication non-adherence is that 
persons who are regularly retained in medical 
care may receive close monitoring, such that 
their medication adherence does not lapse. 
Future studies should include longitudinal 
designs that monitor and collect relevant 
information about patterns of medication 
adherence among persons with and without 
depression.  
 
Several limitations in our study should be noted. 
All measures examined were self-reported, 
which introduces the possibility of recall bias 
and/or report bias (social desirability). In 
particular, reported injection drug use was low, 
which could be due to underreporting because of 
social desirability or recall bias. Due to the small 
sample of transgender persons, we were unable 
to conduct analyses for this group. Future studies 
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should include larger sample sizes of transgender 
persons in examining the relationship between 
depression and behaviors. In our study, injection 
drug users composed a small sample size, and it 
is possible that we had insufficient power to 
detect associations between depression and 
injection drug use. Future studies will benefit 
from larger sample sizes. The MMP 
questionnaire does not assess whether or not the 
individual is taking antidepressant medication. 
By knowing whether or not an individual is 
taking antidepressants, analyses could be 
conducted to assess whether persons with 
untreated depression experience more adverse 
health outcomes than those with treated 
depression. Lastly, the burden of depression 
among HIV-positive adults currently receiving 
care may underestimate the overall burden of 
depression among HIV-positive adults. Those 
seeking medical care may be more health-
conscious and may have fewer adverse health 
behaviors than the general HIV-positive 
population.   
 
The prevalence of major depression among HIV-
positive adults receiving medical care has 
implications for treatment of depression and for 
screening for HIV-positive persons. HIV-specific 
care providers have guidelines for screening and 
treatment of depression (Aberg et al., 2009). 
Although recommended as part of HIV medical 
care guidelines, screening for depression has not 
been consistently implemented in HIV care 
provider settings. For HIV care providers, the 
PHQ-9 is a feasible screening tool (Shacham et 




Future studies should investigate the associations 
between major depression, health behaviors, and 
medication adherence in alternative populations, 
such as urban adults compared to rural adults. 
Moreover, to inform clinical interventions, 
studies are needed to determine the biological 
association between major depression and HIV. 
Future research should also evaluate the 
effectiveness of behavioral interventions aimed 
at mitigating drug use and cigarette use among 
persons living with HIV who are also 
experiencing depression.  
 
Depression and the potential co-occurrence of 
cigarette smoking and non-injection drug use 
negatively affect the overall treatment for HIV-
positive persons by reducing the quality and 
longevity of life. The use of non-injection drugs 
among HIV-positive persons may also increase 
the risk of HIV risk behaviors (Molitor, Truax, 
Ruiz, & Sun, 1998), thus increasing the risk for 
HIV transmission. Treating depression and these 
potentially co-occurring adverse health behaviors 
among HIV-positive adults may increase the 
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